Alpha 2.0
Login Register
» Articles » PMID: 25945612

ERG Deletion is Associated with CD2 and Attenuates the Negative Impact of IKZF1 Deletion in Childhood Acute Lymphoblastic Leukemia

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2015 May 7
PMID 25945612
Citations 3
Authors
M Zaliova
O Zimmermannova
P Dorge
C Eckert
A Moricke
M Zimmermann
J Stuchly
A Teigler-Schlegel
B Meissner
R Koehler
C R Bartram
L Karawajew
P Rhein
J Zuna
M Schrappe
G Cario
M Stanulla
Affiliations
Soon will be listed here.
Citing Articles

Multifaceted roles of gene, perspectives from bench to bedside.

Feng L, Zhang H, Liu T Front Oncol. 2024; 14:1383419.

PMID: 38978740 PMC: 11228169. DOI: 10.3389/fonc.2024.1383419.

Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia.

Aberuyi N, Rahgozar S, Ghodousi E, Ghaedi K Front Oncol. 2020; 9:1496.

PMID: 32010613 PMC: 6978753. DOI: 10.3389/fonc.2019.01496.

Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring deletions.

Pastorczak A, Sedek L, Braun M, Madzio J, Sonsala A, Twardoch M Oncotarget. 2018; 9(40):25971-25982.

PMID: 29899835 PMC: 5995260. DOI: 10.18632/oncotarget.25411.